2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-15784
    NPPM 6748-481
    		Inhibitor 99.60%
    NPPM 6748-481 is a selective inhibitor of the yeast phosphatidylinositol transfer protein (PITP) Sec14.
    NPPM 6748-481
  • HY-112106A
    Diethyl aminoethyl hexanoate citrate
    		99.87%
    Diethyl aminoethyl hexanoate citrate is a compound that is widely used as a plant growth regulator.
    Diethyl aminoethyl hexanoate citrate
  • HY-W011165
    L-Lysyl-L-lysine dihydrochloride
    		98.18%
    L-Lysyl-L-lysine (Lysyllysine) dihydrochloride is an enzyme cleavable basic amino acid. L-Lysyl-L-lysine dihydrochloride can be used for delivering multiple biologically active peptides.
    L-Lysyl-L-lysine dihydrochloride
  • HY-107783
    Sulfo-GMBS
    Sulfo-GMBS is a cross-linking agent widely used in chemical modification and coupling reactions of proteins and peptides. Among the amine-sulfhydryl cross-linkers, Sulfo-GMBS generated the largest number of cross-links and covered most of the cross-links that were identified with AMAS and GMBS.
    Sulfo-GMBS
  • HY-139893
    ERGi-USU-6 mesylate
    		Inhibitor
    ERGi-USU-6 (mesylate) is an ERGi-USU-6 salt derivative that is a new selective inhibitor of ERG positive prostate cancer ( IC50 = 0.089 μM).
    ERGi-USU-6 mesylate
  • HY-124825
    iGOT1-01
    		99.77%
    iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.
    iGOT1-01
  • HY-19971
    ML239
    		99.89%
    ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.
    ML239
  • HY-128356
    SPL-410
    		Inhibitor 99.38%
    SPL-410 is an orally active, highly potent and selective hydroxyethylamine based SPPL2a (Signal Peptide Peptidase Like 2a) inhibitor, with an IC50 of 9 nM.
    SPL-410
  • HY-121212
    Icosabutate
    Icosabutate, an orally active ω-3 polyunsaturated fatty acid, is an aeicosapentaenoic acid (EPA) derivative. Icosabutate overcomes the drawbacks of unmodified EPA for liver targeting and improves insulin sensitivity, hepatic inflammation and fibrosis. Icosabutate is well tolerated, and efficacious in lowering non-high-density lipoprotein cholesterol (non-HDL-C) levels in persistent hypertriglyceridemia .
    Icosabutate
  • HY-153075
    ISR-IN-2
    		98.21%
    ISR-IN-2 (Compound 47) is an inhibitor of the integrated stress response (EC50: 0.8 nM).
    ISR-IN-2
  • HY-B1042
    Oxolamine citrate
    		99.87%
    Oxolamine citrate (SKF-9976 citrate) is an orally active cough suppressant that can be used for the research of respiratory tract diseases. Oxolamine citrate also exhibits anti-inflammatory effect.
    Oxolamine citrate
  • HY-132182
    HPA-12
    		99.40%
    HPA-12 is an intracellular ceramide transport protein inhibitor.
    HPA-12
  • HY-126112
    Mephenoxalone
    		98.57%
    Mephenoxalone inhibits neuron transmission and can relax skeletal muscles by inhibiting the reflex arc.
    Mephenoxalone
  • HY-160791A
    Claramine TFA
    Claramine TFA is a steroidal polyamine. Claramine TFA can regulate the properties of lipid membranes and protect cells from various biological toxins, including misfolded protein oligomers and toxins derived from biological proteins.
    Claramine TFA
  • HY-17480
    Bendazac
    		99.92%
    Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process.
    Bendazac
  • HY-114243
    DpC
    		98.28%
    DpC is an anti-tumor agent. DpC inhibits cancer cell proliferation (IC50: 0.007-0.096 μM). DpC synergizes with multiple anti-cancer therapeutics.
    DpC
  • HY-128047
    GALK1-IN-1
    		98.17%
    GALK1-IN-1 (Compound 4) is a galactokinase inhibitor (IC50: 4.2129 μM).
    GALK1-IN-1
  • HY-103595
    Epirizole
    		99.90%
    Epirizole (Mepirizole) is an orally active NSAID (nonsteroidal anti-inflammatory agent). Epirizole shows anti-inflammatory activity, and can be used in chronic rheumatoid arthritis research.
    Epirizole
  • HY-121872
    DP-b99
    		Chemical
    DP-b99 is a chelator of zinc and calcium ions that acts selectively within cell membranes and has neuroprotective properties in animal models of stroke.
    DP-b99
  • HY-119171
    GSK 366
    		Inhibitor 99.80%
    GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively.
    GSK 366
Cat. No. Product Name / Synonyms Application Reactivity